Cargando…
Follicular Lymphoma: The Management of Elderly Patient
Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma, which typically affects mature adults and elderly, whose median age at diagnosis is 65 years. The natural history of FL appears to have been favorably impacted by the introduction of Rituximab. Randomized clinical trials demo...
Autores principales: | Castellino, Alessia, Santambrogio, Elisa, Nicolosi, Maura, Botto, Barbara, Boccomini, Carola, Vitolo, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224805/ https://www.ncbi.nlm.nih.gov/pubmed/28105297 http://dx.doi.org/10.4084/MJHID.2017.009 |
Ejemplares similares
-
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
por: Margiotta-Casaluci, Gloria, et al.
Publicado: (2023) -
Antibody Therapies for Large B-Cell Lymphoma
por: Novo, Mattia, et al.
Publicado: (2021) -
Managing Follicular Lymphoma in the Elderly Population
por: Tan, Jiao Jie Cherie, et al.
Publicado: (2023) -
Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
por: Castellino, Alessia, et al.
Publicado: (2021) -
Reduced bendamustine for elderly patients with follicular lymphoma
por: Masamoto, Yosuke, et al.
Publicado: (2021)